Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00136851 · ClinicalTrials.gov registry record · Phase 4
Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension
A Phase 4 study, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 259
- Enrollment target
NCT00136851 is a Phase 4 study that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 259 participants.
The verdict
NCT00136851, a Phase 4 study, has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 259 participants
- Enrollment target
Study Summary
This trial is designed to study the efficacy of an amlodipine besylate/benazepril treatment regimen versus an amlodipine treatment regimen in the treatment of severe hypertension.
Interventions
- DRUG amlodipine besylate/benazepril hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 259 participants |
| Start Date | 2004-12 |
| Est. Completion | 2005-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00136851
The ClinicalTrials.gov registry entry for NCT00136851 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 259 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which amlodipine besylate/benazepril hydrochloride is the first listed.
NCT00136851 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00136851 about?
NCT00136851 is a clinical study titled "Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension". This trial is designed to study the efficacy of an amlodipine besylate/benazepril treatment regimen versus an amlodipine treatment regimen in the treatment of severe hypertension.
What is the current status of trial NCT00136851?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 259 participants. The study started on 2004-12. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00136851?
The interventions under investigation include: amlodipine besylate/benazepril hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00136851?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.